How to Buy Pacira Biosciences Stock
Pacira Biosciences Inc
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States.
Pacira Biosciences stock last closed at $23.70, up 0.55% from the previous day, and has increased 33.07% in one year. It has overperformed other stocks in the Drug Manufacturers - Specialty & Generic industry by 0.47 percentage points. Pacira Biosciences stock is currently +44.42% from its 52-week low of $16.41, and -14.25% from its 52-week high of $27.64.
There are currently 43.02M PCRX shares outstanding. The market capitalization of PCRX is $1.02B. In the past 24 hours, 698,000 PCRX shares were traded.
How to Buy Pacira Biosciences Stock
Not sure how to invest in Pacira Biosciences stock? Here's how.
- Figure out where to buy Pacira Biosciences stock: You need to pick an online brokerage, but don't worry - we've tried dozens of online brokerages and apps to help you choose where to buy Pacira Biosciences stock.
- Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your investment account: Pick your payment method and add your information.
- Analyze Pacira Biosciences stock: The Pacira Biosciences ticker symbol is PCRX. Is Pacira Biosciences stock a good investment? Should you buy shares of PCRX? How do PCRX's underlying business fundamentals look? Do top analysts think Pacira Biosciences is a good buy? Why has PCRX's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if PCRX is a good stock to buy).
- Execute your PCRX buy order: Decide if you will purchase PCRX shares at the current market price or use a limit order to buy PCRX stock at a given price.
- Monitor your PCRX position: Create a watchlist to important updates regarding your investment in Pacira Biosciences shares.
Step 1: Figure out where to buy Pacira Biosciences stock
You need an online brokerage account to access the NASDAQ market and buy PCRX stock.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
- Invest in stocks with 0% commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to world financial markets: From Tech to Utilities, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Open a brokerage account
Now that you've selected the right brokerage, it's time to fill out some personal info so you can invest in PCRX stock today.
How to Set Up a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal data to create a new brokerage account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your investment account
Now that you have finished signing up on stock market app, you need to deposit funds:
Watch the video below for more details transferring money into your investment account.
Step 4: Analyze Pacira Biosciences stock
Once you have chosen the best place to buy Pacira Biosciences stock, it's crucial to analyze their stock prior to buying, so you can wrap your head around the risk and opportunity.
Pacira Biosciences shares data
Pacira Biosciences Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis in less time.
You can view all of the due diligence checks on PCRX's stock page.
Is PCRX stock properly valued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge PCRX's true value.
Using relative valuations metrics:
- PCRX may be overvalued based on its P/E ratio of 51.52x, relative to Drug Manufacturers - Specialty & Generic industry P/E ratio of 33.53x
- PCRX could be undervalued based on its P/B ratio of 1.4x, relative to Drug Manufacturers - Specialty & Generic industry P/B ratio of 2.22x
- PCRX may be undervalued based on its PEG ratio of 0.5x
You can access additional valuation research on PCRX's stock here.
A look at PCRX Cashflows and Balance Sheet
Passed Financial Due Diligence Checks:
- There are more short-term assets than short-term liabilities on the PCRX balance sheet.
- There are more short-term assets than long-term liabilities on the PCRX balance sheet.
- PCRX profit margin has gone up from -13.1% to 3% in the past year.
- Total PCRX debt is lower than 5 years ago, relative to shareholder equity.
- PCRX's operating cash flow of $141.44M allows it to safely service it's debt of $425.31M.
Failed Financial Due Diligence Checks:
- PCRX earnings of $60.06M is not sufficient to cover its interest payments.
- PCRX has a relatively high debt to equity ratio of 0.78.
Is it a good time to buy Pacira Biosciences stock, according to Wall Street analysts?
Out of 2 Wall Street analysts who monitor PCRX, the consensus analyst rating on PCRX is a Strong Buy
Please note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dig deeper into what analysts are forecasting on the Pacira Biosciences stock forecast page.
PCRX Trading Indicators
How are PCRX Revenues/Earnings doing?
Last year, PCRX earnings were $21.44M. During the last 5 year, PCRX's earnings have gone up by -30.95% per year. This was slower than the Drug Manufacturers - Specialty & Generic industry average of 0.34%.
Last year, PCRX revenue was $716.79M. In the last five year, PCRX's revenue has increased by 11.22% per year. This was faster than the Drug Manufacturers - Specialty & Generic industry average of 8.53%.
Find out more about PCRX's earnings and revenue performance here.
Latest Insiders Trades at PCRX
In the last year, executives and large shareholders at PCRX have sold more shares than they have bought.
Jonathan Slonin, Chief Medical Officer of PCRX, was the latest PCRX insider to sell. They sold $95,396.40 worth of PCRX shares on Nov 17, 2025.
Get more info about who owns PCRX shares here.
Can I get consistent income from PCRX stock?
No, Pacira Biosciences doesn't provide an income stream by paying out dividends.
PCRX Social Trading Data
One of the primary reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other investors have to say.
Step 5: Execute your PCRX buy order
There are two main options:
- Market order: A market order is an order to buy or sell a stock at the best available price.
Market orders are usually sufficient. - Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
If you want to be certain you're buying or selling at a particular price limit, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want more help with buying stocks on eToro, click the how to video below:
Step 6: Monitor your PCRX position
Now that you own some shares in PCRX, you'll want to stay up-to-date on your company.
Put PCRX on a watchlist to get notified of the latest news about your PCRX stock.
PCRX Feed
How to Buy Stock in Pacira Biosciences
To reiterate, here are the 6 steps to buy stock in Pacira Biosciences:
- Figure out where to buy Pacira Biosciences stock
- Open a brokerage account
- Deposit funds into your investment account
- Analyze Pacira Biosciences stock
- Execute your PCRX buy order
- Monitor your PCRX position
If you are looking for a brokerage, eToro is our recommended venue.
Get Started with eToro TodayIf you would like to keep an eye on your investment in Pacira Biosciences, click the button below.
Other Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.